4 July 2024
Advanced Medical Solutions Group
plc
("AMS" or
the "Group")
Closing of Peters Surgical
acquisition
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a
world-leading specialist in tissue-healing technologies is pleased
to confirm that, following the regulatory
approval of the acquisition of Peters Surgical announced on 27
June, the transaction has been successfully completed and will be
effective from 1 July.
For further information,
please contact:
|
Advanced Medical Solutions Group plc
|
Tel: +44
(0) 1606 545508
|
|
Chris Meredith, Chief Executive
Officer
Eddie Johnson, Chief Financial
Officer
Michael King, Investor
Relations
|
|
|
|
|
|
ICR
Consilium
|
Tel: +44
(0) 20 3709 5700
|
|
Mary-Jane Elliott / Lucy
Featherstone
|
|
|
|
|
|
Evercore
Simon Elliott / Torera
Oyewo
Investec Bank PLC (NOMAD & Broker)
|
Tel: +44
(0) 20 7653 6141
Tel: +44
(0) 20 7597 5970
|
|
Gary Clarence / David
Anderson
|
|
|
HSBC Bank plc (Broker)
|
Tel: 44
(0) 20 7991 8888
|
|
Sam McLennan / Joe Weaving /
Stephanie Cornish
|
|
About Advanced Medical Solutions Group plc
AMS is a world-leading independent
developer and manufacturer of innovative tissue-healing technology,
focused on quality outcomes for patients and value for payers. AMS
has a wide range of surgical products including tissue adhesives,
sutures, haemostats, internal fixation devices and internal
sealants, which it markets under its brands LiquiBand®,
RESORBA®, LiquiBandFix8®, LIQUIFIX™, Peters
Surgical, Ifabond, Vitalitec and Seal-G®. AMS also
supplies wound care dressings such as silver alginates, alginates
and foams through its ActivHeal® brand as well as
under white label. Since 2019, the Group has made seven
acquisitions: Sealantis, an Israeli developer of innovative
internal sealants, Biomatlante, a French developer and manufacturer
of surgical biomaterials, Raleigh, a leading UK coater and
converter of woundcare and bio-diagnostics materials, AFS Medical,
an Austrian specialist surgical business, Connexicon, an Irish
tissue adhesives specialist, Syntacoll a German specialist in
collagen-based absorbable surgical implants and Peters Surgical a
global provider of specialty surgical sutures, mechanical
haemostasis and internal cyanoacrylate devices.
AMS's products, manufactured in the
UK, Germany, France, the Netherlands, Thailand, India, the Czech
Republic and Israel, are sold globally via a network of
multinational or regional partners and distributors, as well as via
AMS's own direct sales forces in the UK, Germany, Austria, France,
Poland, Benelux, India, the Czech Republic and Russia. The Group
has R&D innovation hubs in the UK, Ireland, Germany, France and
Israel. Established in 1991, the Group has more than 1,500
employees. For more information, please
see www.admedsol.com.